Fibroadenoma is the most common benign solid tumor of the breast and the most prevalent breast mass in young women (ages 15-35). It belongs to the fibroepithelial neoplasm group and consists of both stromal and epithelial components. It exhibits hormonal sensitivity; appearing at puberty, potentially enlarging during pregnancy, and undergoing involution after menopause. Typically presents as a mobile, well-circumscribed, rubbery palpable mass. On ultrasound, it appears as an oval/round, parallel-oriented, circumscribed, homogeneously hypoechoic solid mass classified as BI-RADS 3 (probably benign). On mammography, it manifests as a high-density oval mass, or in involuting cases, the pathognomonic coarse 'popcorn' calcification pattern may be seen. On MRI, it demonstrates homogeneous enhancement with a Type I (persistent) kinetic curve. The risk of malignant transformation is extremely low (<0.3%); the risk of cancer in the contralateral breast is slightly elevated (1.5-2 fold). Patients with complex fibroadenoma (containing cysts, sclerosing adenosis, epithelial calcification, or papillary apocrine changes) have a somewhat higher cancer risk.
Age Range
15-45
Peak Age
25
Gender
Female predominant
Prevalence
Very Common
Fibroadenoma is a biphasic neoplasm originating from the terminal ductal lobular unit (TDLU), containing both stromal fibroblasts and epithelial/myoepithelial cells. Hormonal influences (particularly estrogen and progesterone) stimulate stromal proliferation and exert trophic effects on the epithelial component; thus it appears during puberty, grows during pregnancy and lactation, and undergoes involution with postmenopausal estrogen decline. The dense myxoid/hyalinized structure of the stromal component forms the basis of the homogeneously hypoechoic appearance on ultrasound — low acoustic impedance difference ensures smooth sound transmission and posterior acoustic enhancement is observed. During involution, hyaline degeneration, fibrosis, and dystrophic calcification develop; these calcifications produce the characteristic coarse, popcorn-like pattern on mammography — calcium deposition shows homogeneous distribution within the stromal component. On MRI, the well-defined capsule and organized vascular structure of fibroadenoma produces homogeneous enhancement and a Type I (persistent) kinetic curve — contrast agent accumulates slowly and continuously because vascular permeability is at normal levels and neoangiogenesis is absent.
Coarse, irregular, popcorn-like calcification pattern seen on mammography in involuting fibroadenomas. Represents dystrophic calcification of the stromal component and is pathognomonic for fibroadenoma diagnosis. Completely calcified lesions are classified as BI-RADS 2 and require no follow-up.
Oval or round-shaped, parallel-oriented (wider-than-tall), circumscribed, homogeneously hypoechoic solid mass. Usually 1-3 cm in size, with a thin echogenic capsule that may be visible. Internal structure is homogeneous; however, in large fibroadenomas (>3 cm), lobulated contour and onset of heterogeneity may be observed. Posterior acoustic enhancement is typical (unlike most solid masses). Classified as BI-RADS 3 (probably benign) — 6-month follow-up US recommended.
Report Sentence
A parallel-oriented, oval, circumscribed, homogeneously hypoechoic solid mass is seen in the breast with posterior acoustic enhancement; findings are consistent with fibroadenoma and assessed as BI-RADS 3.
On color Doppler US, fibroadenoma typically demonstrates minimal intralesional vascularity or is avascular. A peripheral feeding vessel may be observed but widespread internal vascularity is not expected. In the presence of increased internal vascularity, phyllodes tumor or malignancy should be excluded. Vascularity should be evaluated with power Doppler even at low flow rates; physiologically slightly more vascularity may be seen in young patients.
Report Sentence
Color Doppler examination reveals minimal intralesional vascularity; no widespread internal vascularity is detected; this finding favors fibroadenoma and argues against phyllodes tumor or malignancy.
On mammography, fibroadenoma appears as an oval or round, circumscribed, equal or high-density mass. Margins are sharp and well-defined, and a halo sign (thin radiolucent ring) may be seen — this is a benign finding indicating good separation from surrounding tissues. In young women, mammographic sensitivity may decrease due to dense breast tissue and the mass may be obscured. Lobulated contour may be present but spiculated margins are not expected.
Report Sentence
Mammography demonstrates an oval, circumscribed, equal-density mass with a halo sign; no spiculated margins or architectural distortion are identified; findings are consistent with fibroadenoma.
In involuting fibroadenomas (usually >50 years), coarse, calcified, 'popcorn'-like calcification pattern is observed. These calcifications develop as dystrophic calcification within the stromal component and are pathognomonic for fibroadenoma diagnosis. Calcification may initially be peripheral or partial and can eventually cover the entire lesion over time. A completely calcified fibroadenoma no longer requires follow-up and is classified as BI-RADS 2 (benign).
Report Sentence
A lesion demonstrating coarse, popcorn-like calcification pattern is seen in the breast; this pattern is pathognomonic for involuting fibroadenoma; assessed as BI-RADS 2.
On contrast-enhanced breast MRI, fibroadenoma demonstrates homogeneous enhancement; non-enhancing internal septations may be observed, which is a highly typical finding for fibroadenoma. Kinetic curve analysis shows a Type I (persistent) pattern — contrast intensity increases continuously and progressively, no washout is observed. Hyperintense appearance on T2-weighted sequences (due to myxoid stroma) supports benign character. Mild-moderate diffusion restriction may be seen on DWI but ADC values are above those of malignant masses (usually >1.3 × 10⁻³ mm²/s).
Report Sentence
Contrast-enhanced breast MRI reveals a mass with homogeneous enhancement and non-enhancing internal septations; kinetic curve demonstrates Type I (persistent) pattern; findings are consistent with fibroadenoma in conjunction with T2 hyperintense signal.
On T2-weighted sequences, fibroadenoma typically shows hyperintense signal, reflecting the high water content of the tumor's myxoid stromal component. T2 signal intensity is prominent in myxoid-predominant fibroadenomas. In fibrous-predominant (hyalinized) fibroadenomas, T2 signal may be hypointense because free water content is reduced in fibrous tissue. T2 hyperintensity does not exclude malignancy but homogeneous T2 hyperintensity is an important supportive finding favoring benign character.
Report Sentence
The mass demonstrates homogeneous hyperintense signal on T2-weighted sequences; this finding suggests the presence of myxoid stromal component and supports benign character.
Criteria
Most common type. Contains homogeneous stromal and epithelial components; no cysts, sclerosing adenosis, or papillary changes. Size usually <3 cm.
Distinct Features
Classic homogeneous hypoechoic appearance on US; minimal malignancy risk (<0.1%); can be discharged after 2 years of stable follow-up.
Criteria
Contains at least one of the following features: cysts (>3 mm), sclerosing adenosis, epithelial calcification, or papillary apocrine changes. Defined by Dupont and Page criteria.
Distinct Features
Onset of heterogeneity on US, microcystic areas; cancer risk slightly increased compared to simple fibroadenoma (3.1-fold); closer follow-up recommended.
Criteria
Size >5 cm or weight >500 g. Usually occurs in adolescent period (10-18 years). May show rapid growth and can cause skin stretching.
Distinct Features
Lobulated contour on US, heterogeneous internal structure, prominent vascularity; large circumscribed mass on mammography; differentiation from phyllodes tumor may be difficult — biopsy may be needed; treatment is surgical excision.
Criteria
Characterized by stromal degeneration and dystrophic calcification in the postmenopausal period. Size is reduced or stable. Coarse calcifications are prominent on mammography.
Distinct Features
Popcorn calcification on mammography — pathognomonic; posterior acoustic shadowing on US (due to calcification); BI-RADS 2 — no follow-up needed; no clinical significance.
Distinguishing Feature
Phyllodes tumor is typically >3 cm, rapidly growing, heterogeneous mass with internal cystic/necrotic areas; prominent internal vascularity and irregular margins on US. Fibroadenoma is homogeneous, slow-growing, and smaller.
Distinguishing Feature
Invasive ductal carcinoma is a hypoechoic mass with spiculated margins, non-parallel orientation, and posterior acoustic shadowing; fibroadenoma is parallel, circumscribed, with posterior enhancement. On kinetic curve, IDC shows Type III (washout), fibroadenoma shows Type I (persistent).
Distinguishing Feature
Intraductal papilloma is usually seen as a solid nodule within a dilated duct; common in retroareolar region and associated with bloody nipple discharge. Fibroadenoma is a parenchymal solid mass unrelated to ducts.
Distinguishing Feature
Simple cyst is a completely anechoic, thin-walled fluid lesion with posterior acoustic enhancement; fibroadenoma is a hypoechoic solid mass. No flow within cyst on color Doppler, while fibroadenoma may show minimal peripheral vascularity.
Distinguishing Feature
Hamartoma (fibroadenolipoma) shows a 'breast within a breast' appearance on mammography with a mixture of fat and breast tissue in a thin capsule; fibroadenoma is a homogeneous high-density mass. Hamartoma is heterogeneous in density and usually larger.
Urgency
routineManagement
surveillanceBiopsy
Not NeededFollow-up
6-monthFibroadenoma is a benign lesion with an extremely low risk of malignant transformation (<0.3%). Short-interval follow-up US at 6 months is recommended for typical fibroadenomas classified as BI-RADS 3; after demonstrating stability for 2 years, can be upgraded to BI-RADS 2 and discharged from follow-up. Core biopsy is indicated in giant fibroadenoma (>5 cm) or rapidly growing cases to exclude phyllodes tumor. Complex fibroadenoma carries a slightly increased cancer risk (3.1-fold) and requires closer follow-up. Surgical excision (enucleation) may be performed at patient request or for cosmetic indications. Biopsy is generally not needed in young patients (<25 years) with typical US findings.
Fibroadenomas generally do not require treatment. Stable lesions smaller than 2 cm can be followed up. Biopsy is recommended for rapid growth, large size (>3 cm), or atypical features. Excisional biopsy is required when phyllodes tumor is suspected.